RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 994 filers reported holding RAYTHEON CO in Q2 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $8,441,000 | -32.7% | 64,363 | +12.7% | 0.46% | -18.6% |
| Q4 2019 | $12,547,000 | +10.5% | 57,100 | -1.4% | 0.56% | +0.5% |
| Q3 2019 | $11,358,000 | +15.6% | 57,891 | +2.4% | 0.56% | +10.1% |
| Q2 2019 | $9,828,000 | +54500.0% | 56,524 | +56424.0% | 0.50% | +50400.0% |
| Q1 2019 | $18,000 | -55.0% | 100 | -61.2% | 0.00% | -50.0% |
| Q4 2018 | $40,000 | -29.8% | 258 | -7.2% | 0.00% | -33.3% |
| Q3 2018 | $57,000 | +5.6% | 278 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $54,000 | -34.1% | 278 | -27.0% | 0.00% | -25.0% |
| Q1 2018 | $82,000 | +26.2% | 381 | +10.1% | 0.00% | 0.0% |
| Q4 2017 | $65,000 | +150.0% | 346 | +117.6% | 0.00% | +100.0% |
| Q2 2017 | $26,000 | -25.7% | 159 | -30.9% | 0.00% | -33.3% |
| Q1 2017 | $35,000 | +66.7% | 230 | +53.3% | 0.00% | +50.0% |
| Q4 2016 | $21,000 | -22.2% | 150 | -25.7% | 0.00% | -33.3% |
| Q3 2016 | $27,000 | +35.0% | 202 | +34.7% | 0.00% | +50.0% |
| Q2 2016 | $20,000 | +11.1% | 150 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $18,000 | -28.0% | 150 | -25.7% | 0.00% | -33.3% |
| Q4 2015 | $25,000 | +13.6% | 202 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $22,000 | -8.3% | 202 | -20.2% | 0.00% | 0.0% |
| Q2 2015 | $24,000 | -22.6% | 253 | -9.6% | 0.00% | -40.0% |
| Q1 2015 | $31,000 | 0.0% | 280 | -3.4% | 0.01% | 0.0% |
| Q4 2014 | $31,000 | +40.9% | 290 | +36.2% | 0.01% | +25.0% |
| Q3 2014 | $22,000 | +10.0% | 213 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $20,000 | -23.1% | 213 | -18.4% | 0.00% | -33.3% |
| Q1 2014 | $26,000 | +52.9% | 261 | +15.0% | 0.01% | +20.0% |
| Q3 2013 | $17,000 | -98.7% | 227 | -98.8% | 0.01% | -99.0% |
| Q2 2013 | $1,271,000 | – | 19,229 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
| Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
| PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
| Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |